AVN 65.45 Increased By ▲ 0.50 (0.77%)
BAFL 30.65 Decreased By ▼ -0.86 (-2.73%)
BOP 4.83 Increased By ▲ 0.04 (0.84%)
CNERGY 3.72 Decreased By ▼ -0.12 (-3.13%)
DFML 14.26 Decreased By ▼ -0.15 (-1.04%)
DGKC 41.06 Decreased By ▼ -0.54 (-1.3%)
EPCL 46.56 Decreased By ▼ -0.14 (-0.3%)
FCCL 11.35 Increased By ▲ 0.06 (0.53%)
FFL 5.03 Decreased By ▼ -0.02 (-0.4%)
FLYNG 5.78 Decreased By ▼ -0.04 (-0.69%)
GGL 10.28 Decreased By ▼ -0.17 (-1.63%)
HUBC 67.03 Increased By ▲ 1.39 (2.12%)
HUMNL 5.68 Increased By ▲ 0.02 (0.35%)
KAPCO 27.85 Increased By ▲ 0.10 (0.36%)
KEL 2.19 Increased By ▲ 0.04 (1.86%)
LOTCHEM 24.83 Increased By ▲ 0.48 (1.97%)
MLCF 21.37 Decreased By ▼ -0.11 (-0.51%)
NETSOL 84.20 Decreased By ▼ -0.59 (-0.7%)
OGDC 85.94 Decreased By ▼ -1.31 (-1.5%)
PAEL 11.01 Increased By ▲ 0.03 (0.27%)
PIBTL 4.17 Decreased By ▼ -0.05 (-1.18%)
PPL 74.56 Decreased By ▼ -1.14 (-1.51%)
PRL 13.40 Decreased By ▼ -0.25 (-1.83%)
SILK 0.92 Increased By ▲ 0.03 (3.37%)
SNGP 40.44 Decreased By ▼ -0.89 (-2.15%)
TELE 5.86 Increased By ▲ 0.01 (0.17%)
TPLP 15.42 Decreased By ▼ -0.22 (-1.41%)
TRG 111.63 Decreased By ▼ -0.07 (-0.06%)
UNITY 13.76 Decreased By ▼ -0.22 (-1.57%)
WTL 1.14 Decreased By ▼ -0.02 (-1.72%)
BR100 4,037 Decreased By -26.9 (-0.66%)
BR30 14,412 Decreased By -56.6 (-0.39%)
KSE100 40,471 Decreased By -262.4 (-0.64%)
KSE30 15,163 Decreased By -67.2 (-0.44%)
Business & Finance

Moderna expects to supply second 100mn vaccine doses to US by May-end

  • Moderna said these delays are expected to be resolved in the near term and not expected to impact monthly delivery targets.
  • The US government has so far administered about 25.5 million doses of the two-dose vaccine, with 45.4 million doses supplied, Moderna said.
Published February 16, 2021
Follow us

Moderna Inc said on Tuesday it was moving forward the supply target for the second 100 million of its COVID-19 vaccine doses to the United States by a month to May end.

The biotech firm said short-term delays in the final stages of production and release of filled vials at Moderna's fill and finish contractor Catalent Inc have recently delayed the release of some doses.

Moderna said these delays are expected to be resolved in the near term and not expected to impact monthly delivery targets.

The United States, which is fighting supply constraints for its large-scale efforts to vaccinate most Americans, earlier this month bought an additional 100 million vaccine doses from Moderna, taking the total ordered doses to 300 million.

The company reiterated it was on track to deliver the first 100 million doses by the end of March and also moved forward the delivery of its third 100 million vaccine doses by two months to July end.

The US government has so far administered about 25.5 million doses of the two-dose vaccine, with 45.4 million doses supplied, Moderna said.

An additional 33.2 million doses of the vaccine have been filled in vials and are at various stages of final production and testing before release to the US government, according to the company.

Moderna expects to deliver an average of 30 million to 35 million doses per month for February and March, and 40 million to 50 million doses a month from April through July-end.

The company said it would ship doses to the US as they are produced instead of stockpiling first, potentially affecting its weekly supply numbers.

Comments

Comments are closed.

Moderna expects to supply second 100mn vaccine doses to US by May-end

At least five injured in explosion near Quetta Police Lines

PM vows ‘zero tolerance’ to terrorism

Pakistan expresses unflinching support for Kashmiris on Solidarity Day

Foreign authorities seeking properties/bank accounts info: FBR won’t intimate concerned taxpayer about request

Dar chairs meeting on role of PDFL, SOEs

WB board to consider $78m ‘digital economy’ project next month

PM directs PD to recover Rs1.13bn royalty amount from 2 oil, gas cos

Section 144 imposed in Peshawar

Imran talks of ‘jail bharo’ movement soon

Pakistan to appeal to Taliban leader over mosque bombing